The criteria are:

Size

The size of tumor is an important criterion:

Proximity of Carina Note that resection of tumor with bronchial margin free of tumor is not possible if the lesion is within 2cms from carina.

Extent of Collapse

Invasion of Surrounding Structures
T Numerical Suffix Assignment
  Size Proximity to Carina Extent of Collapse/Pneumo Invasion of Surrounding Structure
T1 < 3 cm - - -
T2 > 3 cm - Lobar atelectasis Visceral pleura
T3 - Within 2 cm from carina Entire lung Chest wall, diaphragm, mediastinal pleura, pericardium
T4 - Involving carina - Heart, great vessels, trachea, esophagus, vertebral body

 

T Stage I am going to give you information about T characteristics of a hypothetical case.

Assign "T" suffix for this patient. Is it T0, T1, T2  or T3 ?

Answer

"T1" is the correct stage in this patient . Let us review AJC classification of T staging:

TX
Tumor either proven by the presence of malignant cells in bronchopulmonary secretions but not visualized bronchoscopically or roentgenographically or cannot be assessed.
T0
No evidence of primary tumor.
Tis
Carcinoma in situ.
T1
A tumor that is 3.0 cm or less in greatest diameter, surrounded by lung or visceral pleura, and without evidence of invasion proximal to a lobar bronchus at bronchoscopy.
T2
A tumor more than 3.0 cm in greatest diameter or a tumor of any size that either invades the visceral pleura or has associated atelectasis or obstructive pneumonitis extending to the hilar region. At bronchoscopy, the proximal extent of demonstrable tumor must be within a lobar bronchus or at least 2.0 cm distal to the carina.
T3
Tumor of any size with direct extension into an adjacent structure such as the parietal pleura or chest wall the diaphragm, or the mediastinal pleura or pericardium; a tumor bronchoscopically demonstrable to involve a main bronchus less than 2.0 cm distal to but not involving carina.
T4
A tumor of any size with invation of the mediastinum or involving heart, great vessels, trachea, esophagus, vertebral body or carina or presence of malignant pleural effusion.